Cargando…
Amelioration of right ventricular systolic function and stiffness in a patient with idiopathic pulmonary arterial hypertension treated with oral triple combination therapy
Right ventricular (RV) function is an important determinant of the prognosis in patients with pulmonary arterial hypertension (PAH). In the context of recent therapeutic progress, there is an increasing need for better monitoring of RV function for management of PAH. We present the case of a 42-year...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5858733/ https://www.ncbi.nlm.nih.gov/pubmed/29488427 http://dx.doi.org/10.1177/2045894018765350 |
_version_ | 1783307703238524928 |
---|---|
author | Nakaya, Toshitaka Tsujino, Ichizo Ohira, Hiroshi Sato, Takahiro Watanabe, Taku Oyama-Manabe, Noriko Nishimura, Masaharu |
author_facet | Nakaya, Toshitaka Tsujino, Ichizo Ohira, Hiroshi Sato, Takahiro Watanabe, Taku Oyama-Manabe, Noriko Nishimura, Masaharu |
author_sort | Nakaya, Toshitaka |
collection | PubMed |
description | Right ventricular (RV) function is an important determinant of the prognosis in patients with pulmonary arterial hypertension (PAH). In the context of recent therapeutic progress, there is an increasing need for better monitoring of RV function for management of PAH. We present the case of a 42-year-old woman with idiopathic PAH who was treated with three oral pulmonary vasodilators, i.e. tadalafil, ambrisentan, and beraprost. At the baseline assessment, the mean pulmonary arterial pressure (mPAP) was 45 mmHg, cardiac index (CI) was 1.36 L/min/m(2), and pulmonary vascular resistance (PVR) was elevated to 21.3 Wood units (WU). However, three months after the start of combination treatment, mPAP and PVR decreased to 42 mmHg and 7.5 WU, respectively, and conventional indices of RV function, such as CI, right atrial area, and right atrial pressure also improved. Beyond three months, however, there were no further improvements in mPAP, PVR, or indices of RV function. In addition, we calculated three recently introduced indices of intrinsic RV function: end-systolic elastance (Ees; an index of RV contractility), Ees/arterial elastance ratio (Ees/Ea; an index of RV/pulmonary arterial coupling), and β (an index of RV stiffness) using cardiac magnetic resonance imaging and Swan-Ganz catheterization measurements. Notably, in contrast to conventional parameters, Ees, Ees/Ea, and β showed persistent improvement during the entire two-year follow-up. The application of Ees, Ees/Ea, and β may play an additional role in a comprehensive assessment of RV function in PAH. |
format | Online Article Text |
id | pubmed-5858733 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-58587332018-03-22 Amelioration of right ventricular systolic function and stiffness in a patient with idiopathic pulmonary arterial hypertension treated with oral triple combination therapy Nakaya, Toshitaka Tsujino, Ichizo Ohira, Hiroshi Sato, Takahiro Watanabe, Taku Oyama-Manabe, Noriko Nishimura, Masaharu Pulm Circ Case Report Right ventricular (RV) function is an important determinant of the prognosis in patients with pulmonary arterial hypertension (PAH). In the context of recent therapeutic progress, there is an increasing need for better monitoring of RV function for management of PAH. We present the case of a 42-year-old woman with idiopathic PAH who was treated with three oral pulmonary vasodilators, i.e. tadalafil, ambrisentan, and beraprost. At the baseline assessment, the mean pulmonary arterial pressure (mPAP) was 45 mmHg, cardiac index (CI) was 1.36 L/min/m(2), and pulmonary vascular resistance (PVR) was elevated to 21.3 Wood units (WU). However, three months after the start of combination treatment, mPAP and PVR decreased to 42 mmHg and 7.5 WU, respectively, and conventional indices of RV function, such as CI, right atrial area, and right atrial pressure also improved. Beyond three months, however, there were no further improvements in mPAP, PVR, or indices of RV function. In addition, we calculated three recently introduced indices of intrinsic RV function: end-systolic elastance (Ees; an index of RV contractility), Ees/arterial elastance ratio (Ees/Ea; an index of RV/pulmonary arterial coupling), and β (an index of RV stiffness) using cardiac magnetic resonance imaging and Swan-Ganz catheterization measurements. Notably, in contrast to conventional parameters, Ees, Ees/Ea, and β showed persistent improvement during the entire two-year follow-up. The application of Ees, Ees/Ea, and β may play an additional role in a comprehensive assessment of RV function in PAH. SAGE Publications 2018-02-28 /pmc/articles/PMC5858733/ /pubmed/29488427 http://dx.doi.org/10.1177/2045894018765350 Text en © The Author(s) 2018 http://creativecommons.org/licenses/by-nc/4.0/ Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Case Report Nakaya, Toshitaka Tsujino, Ichizo Ohira, Hiroshi Sato, Takahiro Watanabe, Taku Oyama-Manabe, Noriko Nishimura, Masaharu Amelioration of right ventricular systolic function and stiffness in a patient with idiopathic pulmonary arterial hypertension treated with oral triple combination therapy |
title | Amelioration of right ventricular systolic function and stiffness in a patient with idiopathic pulmonary arterial hypertension treated with oral triple combination therapy |
title_full | Amelioration of right ventricular systolic function and stiffness in a patient with idiopathic pulmonary arterial hypertension treated with oral triple combination therapy |
title_fullStr | Amelioration of right ventricular systolic function and stiffness in a patient with idiopathic pulmonary arterial hypertension treated with oral triple combination therapy |
title_full_unstemmed | Amelioration of right ventricular systolic function and stiffness in a patient with idiopathic pulmonary arterial hypertension treated with oral triple combination therapy |
title_short | Amelioration of right ventricular systolic function and stiffness in a patient with idiopathic pulmonary arterial hypertension treated with oral triple combination therapy |
title_sort | amelioration of right ventricular systolic function and stiffness in a patient with idiopathic pulmonary arterial hypertension treated with oral triple combination therapy |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5858733/ https://www.ncbi.nlm.nih.gov/pubmed/29488427 http://dx.doi.org/10.1177/2045894018765350 |
work_keys_str_mv | AT nakayatoshitaka ameliorationofrightventricularsystolicfunctionandstiffnessinapatientwithidiopathicpulmonaryarterialhypertensiontreatedwithoraltriplecombinationtherapy AT tsujinoichizo ameliorationofrightventricularsystolicfunctionandstiffnessinapatientwithidiopathicpulmonaryarterialhypertensiontreatedwithoraltriplecombinationtherapy AT ohirahiroshi ameliorationofrightventricularsystolicfunctionandstiffnessinapatientwithidiopathicpulmonaryarterialhypertensiontreatedwithoraltriplecombinationtherapy AT satotakahiro ameliorationofrightventricularsystolicfunctionandstiffnessinapatientwithidiopathicpulmonaryarterialhypertensiontreatedwithoraltriplecombinationtherapy AT watanabetaku ameliorationofrightventricularsystolicfunctionandstiffnessinapatientwithidiopathicpulmonaryarterialhypertensiontreatedwithoraltriplecombinationtherapy AT oyamamanabenoriko ameliorationofrightventricularsystolicfunctionandstiffnessinapatientwithidiopathicpulmonaryarterialhypertensiontreatedwithoraltriplecombinationtherapy AT nishimuramasaharu ameliorationofrightventricularsystolicfunctionandstiffnessinapatientwithidiopathicpulmonaryarterialhypertensiontreatedwithoraltriplecombinationtherapy |